Talking about liver disease on the international circuit

PHI directors Dr Tim Jobson and Neil Stevens attended the AASLD conference in Washington recently to present the work they are doing finding people who are risk of developing liver disease before symptoms appear. As well as a poster presentation and an evening reception, the company issued more details about the most recent developments.

News site Maddyness covered the story, running a piece by Dr Jobson on the PHI system, and specifically how it can help with the capacity challenges the NHS faces at present.

The full article can be found here.
And Healthcarebusiness euro news also covered the story about the Somerset based start up, announcing that PHI would be releasing details of their new tool, the cumulative liver damage index, at the conference. The full story is available here.

Share:

Facebook
Twitter
Pinterest
LinkedIn

Related Posts

The patient perspective

Recently I have been interviewing patients who have been recalled for a review of their liver health using hepatoSIGHT. This is a simple tool that analyses blood tests going back over a number of years and allows a clinician to decide on a cohort of people who might benefit from a more detailed review.

Read More »
This website use cookies to enhance your experience. Please click accept to continue or, Click Here to find out more information.